Resistance and support
110.30
![](https://www.icicidirect.com/Content/images/graph17.png)
Financials( ₹ in Cr) | Zim Laboratories Ltd | Sun Pharmaceuticals Industries Ltd | Divis Laboratories Ltd | Cipla Ltd | Zydus Lifesciences Ltd |
---|---|---|---|---|---|
Price | 110.85 | 1,520.85 | 4,596.45 | 1,480.80 | 1,073.95 |
% Change | 0.41 | 0.30 | 1.64 | -0.01 | 1.60 |
Mcap ₹ Cr | 540.13 | 364,902.86 | 122,021.50 | 119,554.91 | 108,064.50 |
Revenue TTM ₹ Cr | 367.42 | 43,885.68 | 7,767.51 | 15,790.60 | 17,237.40 |
Net Profit TTM ₹ Cr | 17.25 | 8,560.84 | 1,823.38 | 2,513.47 | 1,997.30 |
PE TTM | 31.34 | 36.50 | 76.24 | 28.08 | 28.04 |
1 Year Return | 1.51 | 48.84 | 27.62 | 46.72 | 84.38 |
ROCE | 9.97 | 16.79 | 19.30 | 14.76 | 16.25 |
ROE | 7.86 | 16.46 | 14.89 | 10.66 | 14.05 |
Equity Capital: 238.75 Cr FV: 10.00
Period | MF Net Purchase / (sold) | FII Net |
---|---|---|
LAST 1M | 29,542.69 | 26,564.54 |
LAST 3M | 107,300.08 | -872.81 |
LAST 6M | 187,950.75 | 839.71 |
LAST 12M | 304,454.24 | 86,051.23 |
Date | Action Type | Ratio |
---|---|---|
Dec 22, 2022 | Bonus | 2:1 |
Zim Laboratories Ltd was incorporated in February, 1984 under the name and style of Zim Laboratories Private Limited in the State of Maharashtra. The Company became a Public Limited Company through fresh Certificate of Incorporation issued by the Registrar of Companies, Maharashtra, Mumbai. The Company is engaged in the manufacturing of formulation on drugs and pre formulation ingredients in India and marketing and selling these within and outside India. The Pharma Industry is dominated by Multinationals, Large Indian companies and in the lower end of the market large number of units mainly in the SSI sector. During the year 2019-20, ZIM Health Technologies Limited was acquired thereby resulting as a wholly owned subsidiary of the company . SIA ZIM Laboratories Limited got incorporated as a wholly owned subsidiary in Latvia. In 2023, the Company launched Thinoral (Patented Oral Thin Film technology) as an alternate drug delivery platform across RoW/ Pharmerging Markets and EU.
Sadoday Gyan (Gr Floor), Opp NADT Nelson Square, Nagpur, Maharashtra, 440013
Tel | : | 91-712-2588070 |
: | cs:zimlab.in | |
Website | : | http://www.zimlab.in |
Link Intime India Pvt Ltd
AGM Date (Month) | : | Jul |
Face Value Equity Shares | : | 10 |
Market Lot Equity Shares | : | 1 |
BSE Code | : | 541400 |
NSE Code | : | ZIMLAB |
Book Closure Date (Month) | : | Jul |
BSE Group | : | B |
ISIN | : | INE518E01015 |
You can buy Zim Laboratories Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Zim Laboratories Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Jun 28, 2024 03:58 PM the closing price of Zim Laboratories Ltd was Rs.110.85.
The latest PE ratio of Zim Laboratories Ltd as of Jun 28, 2024 03:58 PM is 31.34
The latest PB ratio of Zim Laboratories Ltd as of Jun 28, 2024 03:58 PM is 0.44
The 52-week high of Zim Laboratories Ltd share price is Rs. 152.70 while the 52-week low is Rs. 89.50
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Jun 28, 2024 03:58 PM, the market cap of Zim Laboratories Ltd stood at Rs. 540.13 Cr.